Understanding and activating immunity against human cancer.
作者信息
Stevenson Freda K, Palucka Karolina
出版信息
Curr Opin Immunol. 2010 Apr;22(2):212-4. doi: 10.1016/j.coi.2010.03.001. Epub 2010 Mar 24.
Abstract
摘要
相似文献
1
Understanding and activating immunity against human cancer.了解并激活针对人类癌症的免疫反应。
Curr Opin Immunol. 2010 Apr;22(2):212-4. doi: 10.1016/j.coi.2010.03.001. Epub 2010 Mar 24.
2
Promise of cancer stem cell vaccine.癌症干细胞疫苗的前景。
Hum Vaccin Immunother. 2015;11(12):2796-9. doi: 10.1080/21645515.2015.1083661.
3
Dendritic cells in cancer immunotherapy.癌症免疫治疗中的树突状细胞。
Eur J Immunol. 2010 Aug;40(8):2123-30. doi: 10.1002/eji.201040630.
4
Immunostimulatory DNA sequences and cancer therapy.免疫刺激DNA序列与癌症治疗
Springer Semin Immunopathol. 2000;22(1-2):107-16. doi: 10.1007/s002810000022.
5
mRNA Cancer Vaccines.信使核糖核酸癌症疫苗
Recent Results Cancer Res. 2016;209:61-85. doi: 10.1007/978-3-319-42934-2_5.
6
Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part I.癌症的细胞免疫疗法：当前概念与临床展望——治疗性癌症疫苗的科学基础与方法。第一部分。
Clin Oncol (R Coll Radiol). 2004 Aug;16(5):356-65. doi: 10.1016/j.clon.2004.03.013.
7
Dendritic cells and immunotherapy for malignant disease.树突状细胞与恶性疾病的免疫治疗
Br J Haematol. 2001 Mar;112(4):874-87. doi: 10.1046/j.1365-2141.2001.02626.x.
8
Cancer Immunotherapy: Theory and Application.癌症免疫疗法：理论与应用
J Immunol Res. 2018 Jun 21;2018:7502161. doi: 10.1155/2018/7502161. eCollection 2018.
9
Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients.
Clin Immunol. 2003 Jan;106(1):10-5. doi: 10.1016/s1521-6616(02)00016-5.
10
Cancer vaccines: dream, reality, or nightmare?癌症疫苗：梦想、现实还是噩梦？
Clin Exp Med. 2002 Nov;2(3):109-18. doi: 10.1007/s102380200015.
引用本文的文献
1
Adenovirus-Inspired Virus-Like-Particles Displaying Melanoma Tumor Antigen Specifically Target Human DC Subsets and Trigger Antigen-Specific Immune Responses.展示黑色素瘤肿瘤抗原的腺病毒启发的病毒样颗粒特异性靶向人类树突状细胞亚群并触发抗原特异性免疫反应。
Biomedicines. 2022 Nov 10;10(11):2881. doi: 10.3390/biomedicines10112881.
2
Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns.母体免疫：其在预防新生儿非感染性相关疾病中的应用新视角
Vaccines (Basel). 2017 Aug 1;5(3):20. doi: 10.3390/vaccines5030020.
3
A plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancer.一种植物表达的偶联疫苗可打破CD4(+)耐受性并诱导针对转移性Her2(+)乳腺癌的强效免疫。
Oncoimmunology. 2016 Apr 22;5(6):e1166323. doi: 10.1080/2162402X.2016.1166323. eCollection 2016 Jun.
4
Optimization of a gene electrotransfer procedure for efficient intradermal immunization with an hTERT-based DNA vaccine in mice.优化基因电转移程序，以提高基于 hTERT 的 DNA 疫苗经皮免疫小鼠的效率。
Mol Ther Methods Clin Dev. 2014 Sep 24;1:14045. doi: 10.1038/mtm.2014.45. eCollection 2014.
5
PMA withdrawal in PMA-treated monocytic THP-1 cells and subsequent retinoic acid stimulation, modulate induction of apoptosis and appearance of dendritic cells.PMA 处理的单核细胞 THP-1 细胞中 PMA 的撤出以及随后的维甲酸刺激，调节细胞凋亡的诱导和树突状细胞的出现。
Cell Prolif. 2013 Jun;46(3):328-47. doi: 10.1111/cpr.12030.
本文引用的文献
1
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.基于痘病毒的 PSA 靶向免疫治疗转移性去势抵抗性前列腺癌的 II 期随机对照试验的总生存分析。
J Clin Oncol. 2010 Mar 1;28(7):1099-105. doi: 10.1200/JCO.2009.25.0597. Epub 2010 Jan 25.
2
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.来自两项关于用西妥昔单抗进行活性细胞免疫疗法治疗晚期前列腺癌的3期随机、双盲、安慰剂对照试验的综合数据。
Cancer. 2009 Aug 15;115(16):3670-9. doi: 10.1002/cncr.24429.
3
Myeloid-derived suppressor cells as regulators of the immune system.髓源性抑制细胞作为免疫系统的调节因子。
Nat Rev Immunol. 2009 Mar;9(3):162-74. doi: 10.1038/nri2506.
4
A prescription for human immunology.人类免疫学的一份处方。
Immunity. 2008 Dec 19;29(6):835-8. doi: 10.1016/j.immuni.2008.12.003.
5
Taking dendritic cells into medicine.将树突状细胞应用于医学。
Nature. 2007 Sep 27;449(7161):419-26. doi: 10.1038/nature06175.
6
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.二价L1病毒样颗粒疫苗针对16型和18型人乳头瘤病毒长达4.5年的持续疗效：一项随机对照试验的随访结果
Lancet. 2006 Apr 15;367(9518):1247-55. doi: 10.1016/S0140-6736(06)68439-0.
7
Immunotherapy: bewitched, bothered, and bewildered no more.免疫疗法：不再被蛊惑、困扰和迷惑。
Science. 2004 Jul 9;305(5681):197-200. doi: 10.1126/science.1099688.
8
Inflammation and cancer.炎症与癌症。
Nature. 2002;420(6917):860-7. doi: 10.1038/nature01322.
9
Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin.一种由RMA、EL-4和MBL-2淋巴瘤呈递的新型肿瘤特异性CTL表位的鉴定揭示了它们的共同起源。
J Immunol. 2000 Jul 15;165(2):869-77. doi: 10.4049/jimmunol.165.2.869.
10
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.幽门螺杆菌相关性胃炎与原发性B细胞性胃淋巴瘤。
Lancet. 1991 Nov 9;338(8776):1175-6. doi: 10.1016/0140-6736(91)92035-z.
Zotero 插件